Fernando Aleman

Fernando Aleman

Company: Navega Therapeutics

Job title: Co-Founder & Chief Scientific Officer


Epigenetic Repression of Nav1.7 to Treat Chronic Pain & Tackle the Opioid Epidemic 11:30 am

DNA-level epigenetic repression of key genes responsible for pain transmission holds great therapeutic potential Highlighting the selectivity and specificity of this approach Discussing the long-lasting nature of this gene therapy approach Challenges and how to overcome themRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.